Searched for
GLAXOSMITHKLINE PTE LTD
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is tough to think positively about the markets when all the news is about blockades, wars, and everything that can disturb the global ec...
- Bulk deals: GSK sells 5.7% stake in HUL in largest ever block dealHere’s who bought what in some of the key bulk deals of the day.
- Trending stocks: HUL shares down 2% as GSK, Horlicks plan to sell stakeShares of Hindustan Unilever traded 1.98 per cent down in trade at 10:03AM on Thursday .
- Strides Pharma suspends sale of Ranitidine tab in USIn a regulatory filing, the company said it has received an Information Request from the USFDA to provide test data related to NDMA impurit...
- Sensex slips below 27000; top twelve stocks in focusThe 50-share Nifty index was trading below its psychological level of 8,100; weighed down by losses in pharma, FMCG, power and IT.
- Twelve stocks in focus in Monday morning tradeIndian markets are expected to trade in a range. Here is a list of twelve stocks which are likely to be in focus today.
- GSK raises India unit stake to 75% via open offerWe are very pleased with the outcome of this transaction, which further increases our exposure to a strategically important market," GSK Ch...
- Govt clears GlaxoSmithKline's Rs 6,400 crore FDI proposalThe Cabinet Committee on Economic Affairs has approved the proposal of GlaxoSmithKline Pte Limited, Singapore for acquisition of 24.33 per ...
- Nine foreign investment proposals worth Rs 798.73 crore approvedThe Ministry said it approved the nine proposals following recommendations of the Foreign Investment Promotion Board (FIPB).
- FIPB to decide on GlaxoSmithKline, other pharma FDI proposalsFIPB will take up tomorrow GlaxoSmithKline's Rs 6,400 crore FDI plan, the largest foreign investment proposal in the pharma sector this fis...
- Maruti Suzuki, Nestle among MNCs lining up to hike stake in Indian armsStake hikes by multinationals gathered pace since June 2010 and also recently when SEBI and RBI modified the rules on minimum public shareh...
- Foreign Investment Promotion Board to consider Tata-SIA proposal on ThursdayFIPB will on Thursday take a call on allowing Singapore Airlines to tie up with Tatas for setting up a full-service airline.
- FIPB meet on Tata-Singapore Airlines proposal postponed to October 24A meeting of the FIPB to consider the Tata-Singapore Airlines proposal to start a full-service airline has been postponed to next week.
- FIPB to take up Tata-SIA, 29 other FDI proposals on FridayFinMin will take a call on Singapore Airlines' proposal for tie-up with Tatas to set up a full-service airline as well as 29 other FDI appl...
- Three FDI proposals worth Rs 38 crore cleared: Finance Ministry"The Central Government has approved three proposals of FDI amounting to Rs 38.09 crore approximately," the ministry said in a statement.
- Foreign Investment Promotion Board gives go ahead to 7 pharma FDI proposalsDIPP, the nodal body for framing FDI policy, wants to review the policy to ensure there are enough safeguards to ensure domestic healthcare...
- FIPB clears seven pharma FDI proposal, defers threeThe FIPB discussed 30 Foreign Direct Investment (FDI) proposals, including 10 from pharma sector.
Load More
